//

Media

Filter by Category

All Blog News Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

April 25, 2025

C-Path’s Stephenson Featured in BioCentury Article

C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...

April 24, 2025

Registration is Now Open for the 2025 C-Path Global Impact Conference

We’re excited to announce that registration is now open for the 2025 C-Path Global Impact Conference...

April 11, 2025

C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s

In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...

April 3, 2025

Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s Disease

A comprehensive, patient-centered conceptual model of early Parkinson’s is lacking and is greatly needed.

April 2, 2025

C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s

C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...

March 10, 2025

C-Path’s Critical Path for Parkinson’s Consortium Welcomes CND Life Sciences

C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP)...

January 14, 2025

Addressing the need for Standardization of Symptomatic Medication Documentation in Parkinson’s Disease Clinical Research: A Call to Action

People with Parkinson's disease (PD) are prescribed a variety of medications to mitigate symptoms and improve their quality...

February 25, 2025

A Framework to Standardize Gait Study Protocols in Parkinson’s Disease

Research over the past twenty years has shown that gait outcomes have a high sensitivity for diagnosing Parkinson's disease (PD)..

February 1, 2025

Understanding what aspects of Parkinson’s disease matter most to patients and families

Understanding what matters to people with Parkinson’s and their family is essential to derive relevant clinical outcome measures

February 1, 2025

Accelerating Parkinson’s Disease Drug Development with Federated Learning Approaches

Parkinson’s Disease is a progressive neurodegenerative disorder afflicting almost 12 million people...

Previous12 3...11 Next